← back to search

Ludger Staib

City Hospital · DE
Area of research
Oncology · Surgery
Research interest
Research interests include Colorectal Cancer Surgical Treatments, Colorectal Cancer Treatments and Studies, Colorectal and Anal Carcinomas, and Immunotherapy and Immune Responses.
h-index
31
citations
5,330
works
140
NIH funding
primary concept
Medicine
email

Recent publications

Prognosis and quality of life in patients with locally advanced rectal cancer after abdominoperineal resection in the CAO/ARO/AIO-04 randomized phase 3 trial
Scientific Reports 2025cited by 4position: middledoi
The stress for surgeons: exploring stress entities with the robotic senhance surgical system
Journal of Robotic Surgery 2024cited by 10position: middledoi
Perioperative or only adjuvant gemcitabine plus nab-paclitaxel for resectable pancreatic cancer (NEONAX)—a randomized phase II trial of the AIO pancreatic cancer group
Annals of Oncology 2022cited by 157position: middledoi
Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Patients With Locally Advanced Rectal Cancer
JAMA Oncology 2021cited by 345position: middledoi
Quality of life in rectal cancer patients with or without oxaliplatin in the randomised CAO/ARO/AIO-04 phase 3 trial
European Journal of Cancer 2020cited by 19position: middledoi
Randomized Phase II Trial of Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: CAO/ARO/AIO-12
Journal of Clinical Oncology 2019cited by 531position: middledoi
Association of Plane of Total Mesorectal Excision With Prognosis of Rectal Cancer
JAMA Surgery 2018cited by 118position: middledoi
Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial
The Lancet Oncology 2015cited by 722position: middledoi
Preoperative chemoradiotherapy and postoperative chemotherapy with fluorouracil and oxaliplatin versus fluorouracil alone in locally advanced rectal cancer: initial results of the German CAO/ARO/AIO-04 randomised phase 3 trial
The Lancet Oncology 2012cited by 698position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Claus Rödel · Goethe University Frankfurt5 papers (2012–2020)Torsten Liersch · Universitätsmedizin Göttingen4 papers (2012–2020)Gerhard G. Grabenbauer · Friedrich-Alexander-Universität Erlangen-Nürnberg4 papers (2012–2020)Werner Hohenberger · Universitätsklinikum Erlangen4 papers (2012–2020)Rolf Sauer · Universitätsklinikum Erlangen4 papers (2012–2020)Michael Ghadimi · Universitätsmedizin Göttingen4 papers (2015–2020)Gunnar Folprecht · Helmholtz-Zentrum Dresden-Rossendorf4 papers (2012–2020)Emmanouil Fokas · DKFZ-ZMBH Alliance3 papers (2018–2020)Philipp Ströbel · University Hospital Heidelberg3 papers (2015–2020)Ralf‐Dieter Hofheinz · Heidelberg University3 papers (2015–2020)Christian Wittekind · Leipzig University3 papers (2012–2018)Ullrich Graeven · Kliniken Maria Hilf3 papers (2012–2020)Anke Schlenska‐Lange · Krankenhaus Barmherzige Brüder3 papers (2012–2019)Hans-Rudolf Raab · Krebsregister Saarland3 papers (2012–2018)Rainer Fietkau · Bayer (Germany)2 papers (2019–2020)Bülent Polat · University of Würzburg2 papers (2019–2020)Wolf O. Bechstein · Goethe University Frankfurt2 papers (2018–2019)Michael Flentje · Ludwig-Maximilians-Universität München2 papers (2019–2020)Torsten Hothorn · Vienna University of Economics and Business2 papers (2012–2015) · 2 papers (2012–2015)